Twenty-five-year Experience With the Medtronic-Hall Valve Prosthesis
NCT00486928 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 816
Last updated 2011-07-25
Summary
Background-:. The Medtronic-Hall (MH) valve was developed and for the first time implanted in Oslo in 1977. A total of 1,104 patients received this valve at Rikshospitalet-Radiumhospitalet HF in the period 1977-87. In the present study we followed all 816 patients undergoing aortic valve replacement (AVR) over a 25-year period.
Conditions
- Aortic Valve Disease
Sponsors & Collaborators
-
Oslo University Hospital
lead OTHER
Principal Investigators
-
Jan L Svennevig, MD,PhD · Rikshospitalet, Oslo
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
- Completion
- 2005-05-31
Countries
- Norway
Study Locations
More Related Trials
-
ADVANTAGE® Prosthetic Heart Valve Long-term Follow-up Trial
NCT01264484 ·Status: TERMINATED
-
Clinical Evaluation of MDT-2111 in Subjects With Small Aortic Annuli and Symptomatic Severe Aortic Stenosis
NCT01634269 ·Status: COMPLETED ·Phase: NA
-
First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System
NCT01487330 ·Status: COMPLETED ·Phase: NA
-
HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve
NCT02097420 ·Status: COMPLETED ·Phase: NA
-
ADVANCE Direct Aortic Study
NCT01676727 ·Status: COMPLETED
-
Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial
NCT01348438 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 ·Status: COMPLETED ·Phase: NA
-
CoreValve Advance International Post Market Study
NCT01074658 ·Status: COMPLETED
-
Assessment of St Jude Medical Portico Re-sheathable Transapical Aortic Valve System
NCT01742598 ·Status: WITHDRAWN ·Phase: NA
-
Optimization of Commissural Alignment During Transcatheter Aortic Valve Implantation With Evolut FX+
NCT07217691 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cardiac Function After Minimally Invasive Aortic Valve Implantation
NCT01972555 ·Status: COMPLETED ·Phase: NA
-
In-vitro Benchmarking of Currently Available Heart Valve Prostheses for Surgical and Percutaneous Treatment of Aortic Stenosis With Small Annulus, Followed by In-vivo Validation
NCT06859255 ·Status: RECRUITING ·Phase: NA
-
Myeloid Cells in Aortic Valve Stenosis
NCT04717219 ·Status: UNKNOWN
-
Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis
NCT02825134 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Aortic Valve Replacement on Myocardial T1 Values in Severe Aortic Valve Stenosis
NCT05404100 ·Status: COMPLETED
-
Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation Study
NCT03775759 ·Status: COMPLETED ·Phase: NA
-
LANDMARK Trial: a Randomised Controlled Trial of Myval THV
NCT04275726 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis
NCT01437098 ·Status: COMPLETED ·Phase: NA
-
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
NCT01675440 ·Status: COMPLETED
-
The Impact of 24/7-phone Support on Readmission After Aortic Valve Replacement, a Randomized Clinical Trial
NCT02522663 ·Status: COMPLETED ·Phase: NA
-
The TransCatheter Valve and Vessels Trial
NCT03424941 ·Status: COMPLETED ·Phase: NA
-
CoreValve Advance-II Study: Prospective International Post-market Study
NCT01624870 ·Status: COMPLETED
-
Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis
NCT00294775 ·Status: UNKNOWN ·Phase: PHASE3
-
Swedish Study on STroke After TAVR
NCT04086836 ·Status: COMPLETED
-
Microembolic Signals and Serum Markers of Neuronal Damage During Transcatheter Aortic Valve Implantation.
NCT01237743 ·Status: COMPLETED